Ishita Drugs Approves Audited Financial Results for FY26

Ishita Drugs & Industries Ltd. announced the approval of its audited financial results for the quarter and year ended March 31, 2026, during a board meeting held on May 30, 2026. The board also approved the Directors’ Report, Corporate Governance report, Management Discussion and Analysis Report, and the notice for the 33rd Annual General Meeting. Additionally, the re-appointment of Internal Auditors for the year 2026-27 was approved, and the Disclosure of Interest of Directors for the same period was taken on record. The auditors issued an unmodified opinion on the financial results.